Paper39201571
Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues.
Zaher A and 3 others. Int J Mol Sci, 2024. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues. Papers, record 39201571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201571
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydrogen Peroxide | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Animals | |
| Oxidative Stress | |
| Tumor Microenvironment | |
| Ascorbic Acid | |
| Superoxide Dismutase | |
| Reactive Oxygen Species |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA217797 | NCI NIH HHS | United States | P01CA217797 | PubMed and NIH | NIH RePORTER |
| R21CA270742 | NIH HHS | United States | R21CA270742 | PubMed and NIH | NIH RePORTER |
| R21 CA270742 | NCI NIH HHS | United States | R21CA270742 | PubMed and NIH | NIH RePORTER |
| P30 CA086862 | NCI NIH HHS | United States | P30CA086862 | PubMed and NIH | NIH RePORTER |
| L998500-G | Radiation Research Foundation | PubMed | PubMed | ||
| P30 CA086862 | NIH HHS | United States | P30CA086862 | PubMed and NIH | NIH RePORTER |
| P01 CA217797 | NIH HHS | United States | P01CA217797 | PubMed and NIH | NIH RePORTER |
| NA | Holden Comprehensive Cancer Center | PubMed | PubMed | ||
| NA | Carver College of Medicine | PubMed | PubMed |
References179
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,075,911 | Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators. | Med Princ Pract | 2013 | https://conductscience.org/library/papers/23075911 | PubMed |
| 2 | 25,794,772 | Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells. | Breast Cancer Res Treat | 2015 | https://conductscience.org/library/papers/25794772 | PubMed |
| 3 | 28,338,196 | Study on the proliferation of human gastric cancer cell AGS by activation of EGFR in H2O2. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28338196 | PubMed |
| 4 | 28,765,155 | Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy. | Cancer Res | 2017 | https://conductscience.org/library/papers/28765155 | PubMed |
| 5 | 24,624,330 | Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+). | Redox Biol | 2014 | https://conductscience.org/library/papers/24624330 | PubMed |
| 6 | 15,705,895 | Controlling tumor growth by modulating endogenous production of reactive oxygen species. | Cancer Res | 2005 | https://conductscience.org/library/papers/15705895 | PubMed |
| 7 | 27,143,992 | The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27143992 | PubMed |
| 8 | 21,778,829 | Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21778829 | PubMed |
| 9 | 16,675,053 | Partial volume rat lung irradiation: the protective/mitigating effects of Eukarion-189, a superoxide dismutase-catalase mimetic. | Radiother Oncol | 2006 | https://conductscience.org/library/papers/16675053 | PubMed |
| 10 | 9,235,895 | Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9235895 | PubMed |
| 11 | 33,723,127 | Oxidative stress and its role in cancer. | J Cancer Res Ther | 2021 | https://conductscience.org/library/papers/33723127 | PubMed |
| 12 | 16,199,533 | Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16199533 | PubMed |
| 13 | 38,927,877 | Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38927877 | PubMed |
| 14 | 20,729,205 | Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20729205 | PubMed |
| 15 | 33,980,575 | Avasopasem manganese synergizes with hypofractionated radiation to ablate tumors through the generation of hydrogen peroxide. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33980575 | PubMed |
| 16 | 30,618,620 | The Binding Properties and Physiological Functions of Recoverin. | Front Mol Neurosci | 2018 | https://conductscience.org/library/papers/30618620 | PubMed |
| 17 | 26,340,608 | Biological chemistry and functionality of protein sulfenic acids and related thiol modifications. | Free Radic Res | 2016 | https://conductscience.org/library/papers/26340608 | PubMed |
| 18 | 35,898,616 | A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP5+, Synergizes with Carboplatin in Treatment of Chemoresistant Ovarian Cell Line. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35898616 | PubMed |
| 19 | 26,530,759 | Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model. | Int J Radiat Oncol Biol Phys | 2015 | https://conductscience.org/library/papers/26530759 | PubMed |
| 20 | 31,911,474 | High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/31911474 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,694,716 | The Triad of NF-κB, HIF-1α, and Oxidative Stress in Hepatocellular Carcinoma: Pathogenesis, Clinical Challenges, and Therapeutic Potential of CIGB-552 in Liver Transplantation. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42694716 | PubMed |
| 42,622,966 | Crosslink Between Neuroinflammation and Oxidative/Nitrosative Status in the Glioblastoma Tumor Microenvironment: Prognostic and Theranostic Impact. | J Neuroimmune Pharmacol | 2026 | https://conductscience.org/library/papers/42622966 | PubMed |
| 42,528,415 | A Ferrous-Supply-Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy. | Small | 2026 | https://conductscience.org/library/papers/42528415 | PubMed |
| 41,477,216 | Exosome-Enhanced Injectable Hydrogels: A Comprehensive Review on Their Emerging Role in Wound Healing. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41477216 | PubMed |
| 40,703,657 | Harnessing the interaction between redox signaling and senescence to restrain tumor drug resistance. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40703657 | PubMed |
| 40,619,791 | A Targeted Redox-Active Dual-Action Pt(IV)-Mn(II) Prodrug Displays Enhanced In Vivo Anticancer Activity. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/40619791 | PubMed |
| 40,480,985 | A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma. | Nat Commun | 2025 | https://conductscience.org/library/papers/40480985 | PubMed |
| 40,352,359 | Targeted and intelligent nano-drug delivery systems for colorectal cancer treatment. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40352359 | PubMed |
| 40,161,259 | Royal jelly and doxorubicin suppressed tumor cells in the xenograft model of lung cancer via the STAT3/FOXM1/ATG7 signaling pathways in athymic nude mice: a biochemical, immunohistochemically and molecular approach. | Toxicol Res (Camb) | 2025 | https://conductscience.org/library/papers/40161259 | PubMed |
| 40,136,648 | Breaking the Feedback Loop of β-Cell Failure: Insight into the Pancreatic β-Cell's ER-Mitochondria Redox Balance. | Cells | 2025 | https://conductscience.org/library/papers/40136648 | PubMed |
| 39,857,360 | MOMAST® Downregulates AQP3 Expression and Function in Human Colon Cells. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39857360 | PubMed |
| 39,484,304 | Exploring Neuroprotection against Radiation-Induced Brain Injury: A Review of Key Compounds. | NeuroSci | 2024 | https://conductscience.org/library/papers/39484304 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201571
GET https://conductscience.org/api/papers/v1/39201571/references?page=2